004370:KRXNongshim Co., Ltd. Analysis
Data as of 2026-03-17 - not real-time
₩369,500.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Nongshim shares are trading at KRW 369,500, well below the 20‑day, 50‑day and 200‑day SMAs (KRW 416,675 / 416,380 / 419,665), indicating a pronounced short‑term weakness. The RSI of 30.3 suggests the stock is approaching oversold territory, while the MACD remains bearish with a negative histogram, reinforcing downside pressure. Despite this technical softness, the DCF‑derived fair value of KRW 603,444 implies a potential upside of roughly 38%, far exceeding the current price. Forward earnings multiple of 11.1× and a price‑to‑sales ratio of 0.64 further support a valuation case for the stock.
Fundamentally, Nongshim delivers modest revenue growth of 3.2% and maintains solid cash reserves (KRW 1.22 trn) against relatively low debt (KRW 176 bn), though the debt‑to‑equity ratio appears elevated. Profitability is thin, with a 4.8% net margin and ROE of 6.2%, but the company offers a 1.66% dividend yield. Market sentiment is bullish (Fear‑Greed Index 79.45 – “Extreme Greed”), and analysts’ consensus is a “Buy” with a mean target of KRW 508,238, suggesting upside continuity. Overall, the stock sits at a defensive consumer staple position, featuring low beta and high volatility, which frames a balanced risk‑reward profile.
Fundamentally, Nongshim delivers modest revenue growth of 3.2% and maintains solid cash reserves (KRW 1.22 trn) against relatively low debt (KRW 176 bn), though the debt‑to‑equity ratio appears elevated. Profitability is thin, with a 4.8% net margin and ROE of 6.2%, but the company offers a 1.66% dividend yield. Market sentiment is bullish (Fear‑Greed Index 79.45 – “Extreme Greed”), and analysts’ consensus is a “Buy” with a mean target of KRW 508,238, suggesting upside continuity. Overall, the stock sits at a defensive consumer staple position, featuring low beta and high volatility, which frames a balanced risk‑reward profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near the identified support level of KRW 363,000
- RSI in oversold region indicating potential short‑term bounce
- Bearish MACD and high 30‑day volatility increasing downside risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF valuation shows ~38% upside from current price
- Strong cash position with net cash exceeding debt
- Analyst consensus of “Buy” and median target price above current levels
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Defensive consumer‑staples sector with low systematic risk (beta ~0.2)
- Sustainable dividend yield and consistent free cash flow generation
- Long‑term upside potential and favorable forward PE relative to peers
Key Metrics & Analysis
Financial Health
Revenue Growth3.20%
Profit Margin4.84%
P/E Ratio11.1
ROE6.18%
ROA3.10%
Debt/Equity6.24
Op. Cash Flow₩268.7B
Free Cash Flow₩168.7B
Technical Analysis
TrendNeutral
RSI30.3
Support₩363,000.00
Resistance₩459,500.00
MA 20₩416,675.00
MA 50₩416,380.00
MA 200₩419,665.00
MACDBearish
VolumeStable
Fear & Greed Index79.45
Valuation
Fair Value₩603,444.18
Target Price₩508,238.10
Upside/Downside37.55%
GradeUndervalued
TypeValue
Dividend Yield1.66%
Risk Assessment
Beta0.21
Volatility38.43%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.